Puma Biotech, Which Had Weak Demand For A Secondary Offering, Is Also Part Of The SEC Tick Size Pilot Program

Puma Biotechnology Inc(NYSE:PBYI) has had one of its most volatile weeks in recent memory thanks to weak demand for a ...